Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

[1]  J. Becker,et al.  Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma? , 2020, Clinical and experimental dermatology.

[2]  E. Richtig,et al.  Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study. , 2020, International journal of surgery.

[3]  E. Nagore,et al.  The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients , 2017, European Journal of Dermatology.

[4]  R. Elashoff,et al.  Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma. , 2017, Journal of the American College of Surgeons.

[5]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[6]  A. Eggermont,et al.  The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  P. Michelozzi,et al.  The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival. , 2016, American journal of surgery.

[8]  P. Rutkowski,et al.  Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival. , 2016, European journal of cancer.

[9]  C. Berking,et al.  Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. , 2016, The Lancet. Oncology.

[10]  J. Malvehy,et al.  Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma. , 2015, European journal of cancer.

[11]  M. Mandalà,et al.  Tissue prognostic biomarkers in primary cutaneous melanoma , 2014, Virchows Archiv.

[12]  M. Kashani-Sabet,et al.  The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival , 2012, Melanoma research.

[13]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[14]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  D. Kurtz,et al.  Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome? , 2008, American journal of surgery.

[16]  A. Eggermont,et al.  Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients: A Multicenter Study in 388 Patients With Positive Sentinel Nodes , 2008, Annals of surgery.

[17]  A. Eggermont,et al.  High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. , 2006, European journal of cancer.

[18]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[19]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  MSc Alyson B. Crawford MD,et al.  Wait Times for Melanoma Surgery: Is There an Association with Overall Survival? , 2017, Annals of Surgical Oncology.

[21]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[22]  Katsumasa Takahashi,et al.  Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer. , 2005, Oral oncology.

[23]  A. Cochran,et al.  Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  S. Leong,et al.  Cytokine profiles of sentinel lymph nodes draining the primary melanoma. , 2002, Annals of surgical oncology.

[25]  W. Heath,et al.  Cross-presentation, dendritic cells, tolerance and immunity. , 2001, Annual review of immunology.

[26]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.